Secondary correction of the nose by PEG-HA
REPORT summary
Patient
A 40-year-old woman sought correction after failed rhinoplasty with inverted V deformity, dorsal hump, and valve collapse.
Results
Results remained natural and stable over 7+ years, demonstrating durability and graft-like integration.
Treatments
Surgical revision was excluded due to lack of cartilage support and prior trauma. Neauvia Intense (PEG-HA 28 mg/ml) was used as a structural rhinofiller. In 2018, 1 ml was injected with a 22G cannula under SMAS, mimicking grafts (extension, spreader, strut), followed by a 1 ml touch-up in 2022.
PRODUCTS used
discover more
CLINICAL CASES
want to know more about
our treatments?
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently based on numerous factors. Outcomes are variable and not guaranteed.